Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy
出版年份 2020 全文链接
标题
Calcineurin Inhibitor-Based Immunosuppression and COVID-19: Results from a Multidisciplinary Cohort of Patients in Northern Italy
作者
关键词
-
出版物
Microorganisms
Volume 8, Issue 7, Pages 977
出版商
MDPI AG
发表日期
2020-06-30
DOI
10.3390/microorganisms8070977
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
- (2020) Victor M Corman et al. Eurosurveillance
- A new coronavirus associated with human respiratory disease in China
- (2020) Fan Wu et al. NATURE
- COVID‐19 in a High‐Risk Dual Heart and Kidney Transplant Recipient
- (2020) Jeffrey J. Hsu et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Two distinct cases with COVID‐19 in kidney transplant recipients
- (2020) Yaerim Kim et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID‐19 in solid organ transplant recipients: A single‐center case series from Spain
- (2020) Mario Fernández‐Ruiz et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Successful recovery of COVID‐19 pneumonia in a renal transplant recipient with long‐term immunosuppression
- (2020) Lan Zhu et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID-19 in kidney transplant recipients
- (2020) Ilaria Gandolfini et al. AMERICAN JOURNAL OF TRANSPLANTATION
- COVID‐19 in solid organ transplant recipients: Initial report from the US epicenter
- (2020) Marcus R. Pereira et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation?
- (2020) Elena Guillen et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Clinical course of COVID-19 in a series of patients with chronic arthritis treated with immunosuppressive targeted therapies
- (2020) Sara Monti et al. ANNALS OF THE RHEUMATIC DISEASES
- Direct oral anticoagulant plasma levels’ striking increase in severe COVID‐19 respiratory syndrome patients treated with antiviral agents: The Cremona experience
- (2020) Sophie Testa et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- COVID-19 and Italy: what next?
- (2020) Andrea Remuzzi et al. LANCET
- COVID-19: consider cytokine storm syndromes and immunosuppression
- (2020) Puja Mehta et al. LANCET
- Coronaviruses and Immunosuppressed Patients: The Facts During the Third Epidemic
- (2020) Lorenzo D’Antiga LIVER TRANSPLANTATION
- Covid-19 and Kidney Transplantation
- (2020) Enver Akalin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Case report: A kidney transplant patient with mild COVID‐19
- (2020) Emre Arpali et al. Transplant Infectious Disease
- Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis
- (2020) Alfonso J. Rodriguez-Morales et al. Travel Medicine and Infectious Disease
- Identification of Kidney Transplant Recipients with Coronavirus Disease 2019
- (2020) Hui Zhang et al. EUROPEAN UROLOGY
- Intrapatient Variability of Tacrolimus Exposure in Solid Organ Transplantation: A Novel Marker for Clinical Outcome
- (2019) Dirk R.J. Kuypers CLINICAL PHARMACOLOGY & THERAPEUTICS
- Influences of cyclosporin A and non-immunosuppressive derivatives on cellular cyclophilins and viral nucleocapsid protein during human coronavirus 229E replication
- (2019) Yue Ma-Lauer et al. ANTIVIRAL RESEARCH
- MERS, SARS and other coronaviruses as causes of pneumonia
- (2017) Yudong Yin et al. RESPIROLOGY
- Cyclosporine in Anti-Jo1-positive Patients with Corticosteroid-refractory Interstitial Lung Disease
- (2013) L. Cavagna et al. JOURNAL OF RHEUMATOLOGY
- Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
- (2012) Javier Carbajo-Lozoya et al. VIRUS RESEARCH
- Cyclosporin A inhibits the replication of diverse coronaviruses
- (2011) A. H. de Wilde et al. JOURNAL OF GENERAL VIROLOGY
- The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
- (2011) Susanne Pfefferle et al. PLoS Pathogens
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started